Trial Profile
Phase I/II study of 124I-8H9 (B7-H3) in patients with Diffuse Intrinsic Pontine Glioma
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Omburtamab-I-124 (Primary)
- Indications Diffuse intrinsic pontine glioma
- Focus Therapeutic Use
- 15 Sep 2016 New trial record